Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 18, 2010 09:00 ET | Source: Marina Biotech, Inc.

Marina Biotech Achieves Significant Improvements in siRNA Delivery via New DiLA2-Based Compositions

BOTHELL, WA--(Marketwire - November 18, 2010) - Marina Biotech, Inc. (NASDAQ: MRNA), a leading RNAi-based drug discovery and development company, today presented data outlining a major breakthrough...
November 15, 2010 16:30 ET | Source: Marina Biotech, Inc.

Marina Biotech, Inc. Announces Revised Third Quarter 2010 Financial Results

BOTHELL, WA--(Marketwire - November 15, 2010) - Marina Biotech, Inc. (NASDAQ: MRNA), a leading RNAi-based drug discovery and development company, today reported revised financial results for the...
November 10, 2010 16:04 ET | Source: Marina Biotech, Inc.

Marina Biotech, Inc. Announces Third Quarter 2010 Financial Results

BOTHELL, WA--(Marketwire - November 10, 2010) - Marina Biotech, Inc. (NASDAQ: MRNA), a leading RNAi-based drug discovery and development company, today reported financial results for the third...
November 08, 2010 09:00 ET | Source: Marina Biotech, Inc.

Marina Biotech Completes Previously Announced Financing

BOTHELL, WA--(Marketwire - November 8, 2010) - Marina Biotech, Inc. (NASDAQ: MRNA), a leading RNAi-based drug discovery and development company, announced today that it has closed its previously...
November 05, 2010 09:25 ET | Source: MRNA

Marina Biotech Announces Financing for up to $8.7 Million

BOTHELL, WA--(Marketwire - November 5, 2010) - Marina Biotech, Inc. (NASDAQ: MRNA), a leading RNAi-based drug discovery and development company, announced today that it has entered into a securities...
November 04, 2010 09:00 ET | Source: Marina Biotech, Inc.

Marina Biotech Publishes Research on the Advantages of Its Novel UsiRNA Construct

BOTHELL, WA--(Marketwire - November 4, 2010) - Marina Biotech, Inc. (NASDAQ: MRNA), a leading RNAi-based drug discovery and development company, today announced the publication of "Improved...
November 03, 2010 16:30 ET | Source: Marina Biotech, Inc.

Marina Biotech, Inc. to Report Third Quarter Results on November 10, 2010 at 4:30 p.m. Eastern Time

BOTHELL, WA--(Marketwire - November 3, 2010) - Marina Biotech, Inc. (NASDAQ: MRNA), a leading RNAi-based drug discovery and development company, today announced that it will host a conference...
November 03, 2010 08:30 ET | Source: Marina Biotech, Inc.

Marina Biotech Announces Clinical Protocol Approval of CEQ508 at Massachusetts General Hospital

BOTHELL, WA--(Marketwire - November 3, 2010) - Marina Biotech, Inc. (NASDAQ: MRNA), a leading RNAi-based drug discovery and development company, today announced institutional site approval at...
November 01, 2010 16:01 ET | Source: Marina Biotech, Inc.

Marina Biotech Awarded $733,000 in Grants for Qualifying Therapeutic Development Projects

BOTHELL, WA--(Marketwire - November 1, 2010) - Marina Biotech, Inc. (NASDAQ: MRNA), a leading RNAi-based drug discovery and development company, announced today that it was awarded cash grants...
October 26, 2010 08:30 ET | Source: Marina Biotech, Inc.

Marina Biotech Announces Interim Safety Results of Long-Term Toxicology Study

BOTHELL, WA--(Marketwire - October 26, 2010) - Marina Biotech, Inc. (NASDAQ: MRNA), a leading RNAi-based drug discovery and development company, today announced interim results of a six month...